Aditi Milind Panandikar has submitted to the Exchange a copy of Disclosures under Regulation 10(6) Report to stock Exchange in respect of any acquisition made in reliance upon exemption provided for in regulation 10 of SEBI (SAST) Regulations, 2011
INDOCO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aditi Milind Panandikar, who appears to be part of the promoter family of Indoco Remedies, has filed a disclosure with the stock exchange under Regulation 10(6) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. This regulation applies when an acquisition is made under one of the exemptions provided in Regulation 10, which typically cover inter se transfers among promoters or creeping acquisitions within the prescribed limits. The specific number of shares, price, percentage change in promoter holding, and direction (buy/transfer) are not mentioned in the headline. Without these details, the exact impact on promoter shareholding cannot be quantified from this filing alone.
This is a routine regulatory disclosure and does not indicate any change in overall control of the company. Shareholders may want to check the detailed disclosure on the BSE/NSE portal to understand if promoter group holding has shifted marginally, but the announcement itself is informational and likely non-material.